CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study. Conference Poster 2014 Congress communication uri icon

authors

  • Crespo M
  • Esteban H
  • GUTIERREZ RODERO, FELIX
  • Hernandez J
  • Iribarren JA
  • Mariño Ae
  • Pasquau J
  • Pérez-Molina JA
  • Ribero A
  • Rubio R
  • Santos J
  • Sanz J
  • Terron A
  • Valero IP

publication date

  • 2014